⌘K
Loading ticker…
As of 2026-08-24, Natera, Inc. Common Stock (NTRA) has a 3-month relative strength percentile of 96 and a leadership percentile of 97 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 70. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.0%, relative volume 0.83×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
NTRA is in a stage 2 uptrend, week 8. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 19.2% / 42.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
NTRA is held by 41 ETFs as of May 2026. Top owner: VHT at 0.46% weight, $88M notional. Top 3 carry $203M.
Held by 156 ETFs · $3.7B across latest filings · largest weight 6.65% (HELX).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.46% | $88M | +0.06 pp |
| SCHGSchwab U.S. Large-Cap Growth ETF | 0.11% | $66M | — |
| VONGVanguard Russell 1000 Growth ETF | 0.09% | $49M | — |
| GSLC | 0.26% | $40M | −0.05 pp |
| SCHXSchwab U.S. Large-Cap ETF |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.05% |
| $33M |
| — |
| SCHBSchwab U.S. Broad Market ETF | 0.04% | $18M | — |
| QQQJ | 1.47% | $16M | +0.05 pp |
| CGMM | 0.48% | $14M | +0.06 pp |
| ONEQ | 0.07% | $8M | — |
| ESGV | 0.05% | $7M | — |
Showing 10 of 41 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NTRA Jan avg: 6.20% median: 6.07% win: 100% σ: 4.49% n: 4 2022-04-12 → 2026-07-31 | NTRA Feb avg: 5.55% median: 1.55% win: 50% σ: 20.53% n: 4 2022-04-12 → 2026-07-31 | NTRA Mar avg: 1.78% median: 0.94% win: 50% σ: 10.40% n: 4 2022-04-12 → 2026-07-31 | NTRA Apr avg: -2.23% median: 1.55% win: 60% σ: 8.66% n: 5 2022-04-12 → 2026-07-31 | NTRA May avg: 4.98% median: 4.50% win: 80% σ: 7.95% n: 5 2022-04-12 → 2026-07-31 | NTRA Jun avg: 6.03% median: 3.29% win: 80% σ: 9.45% n: 5 2022-04-12 → 2026-07-31 | NTRA Jul avg: -0.43% median: -5.45% win: 20% σ: 19.88% n: 5 2022-04-12 → 2026-07-31 | NTRA Aug avg: 19.02% median: 20.69% win: 100% σ: 11.24% n: 4 2022-04-12 → 2026-07-31 (current) | NTRA Sep avg: -8.17% median: -7.69% win: 25% σ: 13.36% n: 4 2022-04-12 → 2026-07-31 | NTRA Oct avg: 3.81% median: 1.22% win: 50% σ: 15.15% n: 4 2022-04-12 → 2026-07-31 | NTRA Nov avg: 22.02% median: 29.38% win: 75% σ: 24.89% n: 4 2022-04-12 → 2026-07-31 | NTRA Dec avg: -0.02% median: -3.19% win: 25% σ: 8.10% n: 4 2022-04-12 → 2026-07-31 |